§ COMPARE REGULATORS

NMPA vs MFDS: Medical Device Regulatory Comparison

Compare the medical device registration pathways, classification, and regulatory requirements of NMPA (China) vs MFDS (South Korea).

NMPA

National Medical Products Administration (China)

China

China's NMPA regulates medical devices through CMDE (Center for Medical Device Evaluation) technical reviews. China uses a three-class risk-based system. Foreign manufacturers must appoint a Marketing

CLASSES

Class I, II, III

PATHWAY

NMPA Registration (CMDE review)

KEY FUNCTIONS
  • CMDE technical review
  • MAH (Marketing Authorization Holder) system
  • In-country testing requirements
  • Clinical trial oversight
  • NMPA registration certificates

MFDS

Ministry of Food and Drug Safety (South Korea)

South Korea

MFDS regulates medical devices in South Korea using a four-class system. The Korean Good Manufacturing Practice (KGMP) standard is required for all manufacturers. South Korea is an MDSAP participating

CLASSES

Class I, II, III, IV

PATHWAY

MFDS registration

KEY FUNCTIONS
  • KGMP compliance
  • Technical documentation review
  • MDSAP participation
  • Clinical trial approval
  • Device registration

MedFlux monitors both NMPA and MFDS in real time — every regulatory change, safety alert, and market signal delivered in under 90 seconds.

COMPARE LIVE DATA FREE →

§ OTHER COMPARISONS